168 related articles for article (PubMed ID: 31534029)
1. Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study.
Chen W; Safari A; FitzGerald JM; Sin DD; Tavakoli H; Sadatsafavi M
Thorax; 2019 Dec; 74(12):1113-1119. PubMed ID: 31534029
[TBL] [Abstract][Full Text] [Related]
2. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
[TBL] [Abstract][Full Text] [Related]
3. Direct health care costs associated with asthma in British Columbia.
Sadatsafavi M; Lynd L; Marra C; Carleton B; Tan WC; Sullivan S; Fitzgerald JM
Can Respir J; 2010; 17(2):74-80. PubMed ID: 20422063
[TBL] [Abstract][Full Text] [Related]
4. The Economic Burden of Asthma in the United States, 2008-2013.
Nurmagambetov T; Kuwahara R; Garbe P
Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
[TBL] [Abstract][Full Text] [Related]
5. Excess medical costs in patients with asthma and the role of comorbidity.
Chen W; Lynd LD; FitzGerald JM; Marra CA; Balshaw R; To T; Tavakoli H; Sadatsafavi M;
Eur Respir J; 2016 Dec; 48(6):1584-1592. PubMed ID: 27824603
[TBL] [Abstract][Full Text] [Related]
6. Excess economic burden of comorbidities in COPD: a 15-year population-based study.
Chen W; FitzGerald JM; Sin DD; Sadatsafavi M;
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751416
[TBL] [Abstract][Full Text] [Related]
7. Ten-year trends in direct costs of asthma: a population-based study.
Tavakoli H; FitzGerald JM; Chen W; Lynd L; Kendzerska T; Aaron S; Gershon A; Marra C; Sadatsafavi M;
Allergy; 2017 Feb; 72(2):291-299. PubMed ID: 27455382
[TBL] [Abstract][Full Text] [Related]
8. The projected economic and health burden of sub-optimal asthma control in Canada.
Zafari Z; Sadatsafavi M; Chen W; FitzGerald JM
Respir Med; 2018 May; 138():7-12. PubMed ID: 29724396
[TBL] [Abstract][Full Text] [Related]
9. The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database.
Bourdin A; Fabry-Vendrand C; Ostinelli J; Ait-Yahia M; Darnal E; Bouee S; Laurendeau C; Bureau I; Gourmelen J; Chouaid C
J Allergy Clin Immunol Pract; 2019; 7(5):1477-1487. PubMed ID: 30685573
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.
McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
Semin Arthritis Rheum; 2020 Feb; 50(1):77-83. PubMed ID: 31358362
[TBL] [Abstract][Full Text] [Related]
11. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
[TBL] [Abstract][Full Text] [Related]
12. The natural history of severe asthma and influences of early risk factors: a population-based cohort study.
Chen W; Marra CA; Lynd LD; FitzGerald JM; Zafari Z; Sadatsafavi M
Thorax; 2016 Mar; 71(3):267-75. PubMed ID: 26732738
[TBL] [Abstract][Full Text] [Related]
13. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
15. Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey.
Jantunen J; Haahtela T; Salimäki J; Linna M; Mäkelä M; Pelkonen A; Kauppi P
Int Arch Allergy Immunol; 2019; 179(4):273-280. PubMed ID: 30999310
[TBL] [Abstract][Full Text] [Related]
16. Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting.
Zeiger RS; Schatz M; Dalal AA; Qian L; Chen W; Ngor EW; Suruki RY; Kawatkar AA
J Allergy Clin Immunol Pract; 2016; 4(1):120-9.e3. PubMed ID: 26439182
[TBL] [Abstract][Full Text] [Related]
17. Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada.
Ng B; Sadatsafavi M; Safari A; FitzGerald JM; Johnson KM
BMJ Open; 2019 Nov; 9(11):e031306. PubMed ID: 31699732
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.
Li Q; Blume SW; Huang JC; Hammer M; Ganz ML
J Med Econ; 2015; 18(12):1020-8. PubMed ID: 26134917
[TBL] [Abstract][Full Text] [Related]
20. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
